clinical 3,187 words KG: DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD
Contents

DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (15)

Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.79
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.76
APOE Isoform Conversion Therapy
Score: 0.72
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.72
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.82
Competitive APOE4 Domain Stabilization Peptides
Score: 0.78
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.76
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.75
APOE Isoform Expression Across Glial Subtypes
Score: 0.74
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.74
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.72
Lysosomal Calcium Channel Modulation Therapy
Score: 0.70
FOXO3-Longevity Pathway Epigenetic Reprogramming
Score: 0.63
Blood-Brain Barrier SPM Shuttle System
Score: 0.53
Vocal Cord Neuroplasticity Stimulation
Score: 0.52

Related Analyses (16)

Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · completed
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived

Related Experiments (14)

Cytochrome Therapeutics
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
Levodopa-Induced Dyskinesias Mechanism — Experiment Design
validation · proposed · Score: 0.40
Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · completed · Score: 0.90

See Also (15)

Lecanemab CLARITY-AD Trial
clinical · Pages share 4 hypotheses
TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di
clinical · Pages share 4 hypotheses
al002-trem2-agonist-alzheimers
clinical_trial · Pages share 4 hypotheses
Donanemab TRAILBLAZER-ALZ 2 Trial
clinical · Pages share 4 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 4 hypotheses

Knowledge Graph (3 edges)

DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD references APOE
DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD references GFAP
DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulation for AD references BDNF

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.